T2 Biosystems Inc

NASDAQ:TTOO   3:59:32 PM EDT
0.38
-0.02 (-4.25%)
Other Pre-Announcement

T2 Biosystems Announces The Initiation Of The T2resistance Panel Clinical Trial

Published: 01/11/2022 14:25 GMT
T2 Biosystems Inc (TTOO) - T2 Biosystems Announces the Initiation of the T2resistance® Panel Clinical Trial.
T2 Biosystems Inc - Plans to File FDA Submission for T2resistance Panel in 2022.